Eton Pharmaceuticals Inc: Navigating Market Fluctuations with a 528.31M Market Cap

The market performance of Eton Pharmaceuticals Inc has been somewhat stable. Over the past year, the company’s stock achieved a high of $21.48 on 05/14/25, with the lowest value for the same timeframe being $3.18, recorded on 06/20/24.

52-week price history of ETON Stock

A stock’s 52-week high and low prices can reveal a great deal about its present condition and potential future performance. Eton Pharmaceuticals Inc’s current trading price is -8.29% away from its 52-week high, while its distance from the 52-week low is 519.50%. The stock’s price range during this period has fluctuated between $3.18 and $21.48. Shares of the company, which operates in the Healthcare sector, recorded a trading volume of around 0.66 million for the day, which was evidently higher than the average daily volume of 0.26 million over the last three months.

Financial Performance and Market Capitalization

Eton Pharmaceuticals Inc (ETON) has experienced a quarterly rise of 17.19% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 528.31M and boasts a workforce of 31 employees.

Moving average and trading volume data

Based on Barchart.com data, the company’s moving average over the 100-day period was 14.93, with a change in price of +7.79. Similarly, Eton Pharmaceuticals Inc recorded 273,792 in trading volume during the last 100 days, posting a change of +65.41%.

ETON Debt-to-equity ratio analysis

The debt-to-equity (D/E) ratio is a valuable metric that offers insight into a company’s financial health and standing in the market. This ratio is calculated by dividing a company’s current total liabilities by its shareholders’ equity. The D/E ratio illustrates the extent of debt a company is utilizing to support its assets in relation to the value of its shareholders’ equity. At the time of writing, the total D/E ratio for ETON stands at 1.23. Similarly, the long-term debt-to-equity ratio is also 1.23.

ETON Stock Stochastic Average

The raw stochastic average for Eton Pharmaceuticals Inc over the last 50 days is presently at 82.87%. This reflects a surge from the raw stochastic average of the previous 20 days, which was noted at 77.61%. Further, the company’s Stochastic %K and %D values for the last 20 days were 68.95% and 76.62%, respectively.

ETON Stock Price Performance Analysis

A mixed performance in the stock price over the year has left investors with either an optimistic or pessimistic outlook, depending on their point of view. The metric has seen a significant gain of 47.90% since the start of this calendar year. Looking back over the last six months, we can see a weaker performance of 102.88%. Over the past 30 days, the price of ETON has fallen by 38.83%. And in the last five days, it has surged by 13.68%.

Invest Chronicle
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.